The subsequent in vitro results indicated that suppression of breast cancer-induced osteoclastogenesis with CSBTA was mainly accompanied by suppression of the mRNA levels of Rankl in cancer cells (Figure 5). The gene discussed is TNFSF11; the disease is breast cancer.